Ranbaxy Buyers Seek OK On $485M Deal In Generics MDL

By Hailey Konnath · April 22, 2022, 11:37 PM EDT

Ranbaxy Pharmaceuticals drug purchasers asked a Massachusetts federal court Friday to approve their proposed $485 million global settlement with the generic-drug maker and its parent company over antitrust claims, arguing that...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Ranbaxy Generic Drug Application Antitrust Litigation

Case Number

1:19-md-02878

Court

Massachusetts

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

February 13, 2019